AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimip-MF 4/1000 SR Tablet

Prescription Icon
Prescription Required

Marketer

Roussel Laboratories Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (1000mg)

Overview Glimip-MF 4/1000 SR Tablet

DiaBeta-Duo 4/1000 SR tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation aids in regulating blood glucose levels. Administer DiaBeta-Duo 4/1000 SR tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even if feeling well or if blood sugar is controlled; abrupt cessation without consulting your doctor can elevate blood sugar, risking complications including kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, fruit juice) are crucial. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Inform your physician of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or lactating individuals should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Glimip-MF 4/1000 SR Tablet

Managing type 2 diabetes

Major Benefits of Glimip-MF 4/1000 SR Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimip-MF 4/1000 SR Tablet should be administered with a meal.

Common Side effects of Glimip-MF 4/1000 SR Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimip-MF 4/1000 SR Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimip-MF 4/1000 SR Tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.

How Glimip-MF 4/1000 SR Tablet works:

Glimepiride/Metformin 4mg/1000mg extended-release tablets (e.g., Glimip-MF 4/1000 SR) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts triply: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimip-MF 4/1000 SR Tablet and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimip-MF 4/1000 SR Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimip-MF 4/1000 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimip-MF 4/1000 SR Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimip-MF 4/1000 SR Tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimip-MF 4/1000 SR Tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, the medication is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimip-MF 4/1000 SR Tablet :

Should you forget a Glimip-MF 4/1000 SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimip-MF 4/1000 SR Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimip-MF 4/1000 SR Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimip-MF 4/1000 SR Tablets can cause lactic acidosis, a serious, potentially life-threatening condition characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimip-MF 4/1000 SR Tablets and seek immediate medical attention.
Glimip-MF 4/1000 SR Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimip-MF 4/1000 SR Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimip-MF 4/1000 SR Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimip-MF 4/1000 SR Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimip-MF 4/1000 SR Tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimip-MF 4/1000 SR Table...
115
MRP 140
17% off